VERRICA PHARMACEUTICALS INC. - Daily - Technical analysis published on 09/25/2024 (GMT)
- 93
- 0
I am delighted to see that my first price objective has been achieved. I hope you've taken advantage of it.
Click here for a new analysis!
Click here for a new analysis!
- Timeframe : Daily
- - Analysis generated on
- Status : TARGET REACHED
Summary of the analysis
Trends
Short term:
Strongly bearish
Underlying:
Strongly bearish
Technical indicators
22%
56%
22%
My opinion
Bearish under 1.77 USD
My targets
1.48 USD (-12.60%)
0.70 USD (-58.58%)
My analysis
VERRICA PHARMACEUTICALS INC. is part of a very strong bearish trend. Traders may consider trading only short positions (for sale) as long as the price remains well below 1.77 USD. The next support located at 1.48 USD is the next bearish objective to target. A bearish break of this support would revive the bearish momentum. The bearish movement could then continue towards the next support located at 0.70 USD. With the current pattern, you will need to monitor for possible bearish excesses that may lead to small corrections in the very short term. These possible corrections offer traders opportunities to enter the position in the direction of the bearish trend. Trying to profit from the purchase of these possible corrections may seem risky.
Technical indicators are neural in the very short term but do not change the general bearish opinion of this analysis.
Force
0
10
7.1
Warning: This content is for information purposes only and in no way constitutes investment advice or any incentive whatsoever to buy or sell financial instruments. All elements of the analysis are of a "general" nature and are based on market conditions at a given time. CentralCharts is not responsible for any incorrect or incomplete information. Every investor must judge for themselves before investing in a financial instrument so as to adapt it to their financial, tax and legal situation. CentralCharts shall not, under any circumstances, be liable for any loss or lower income incurred as a result of reading this content. Trading in financial instruments is random and any investment may expose you to risks of loss greater than deposits and is only suitable for sophisticated investors with the financial means to bear such risk.
This analysis was given by Nelff. Take part yourself by sharing additional analysis on another time unit:
Additional analysis
Quotes
VERRICA PHARMACEUTICALS INC. rating 1.69 USD. The price is lower by -3.98% since the last closing and was between 1.67 USD and 1.77 USD. This implies that the price is at +1.20% from its lowest and at -4.52% from its highest.1.67
1.77
1.69
The Central Gaps scanner detects a bullish opening marking the presence of buyers ahead of sellers at the opening but not sufficiently marked to allow the price to register a quotation gap.
Bullish opening
Type : Bullish
Timeframe : Openning
A study of price movements over other periods shows the following variations:
New LOW record (5 years)
Type : Bearish
Timeframe : Weekly
New LOW record (1 year)
Type : Bearish
Timeframe : Weekly
New LOW record (1st january)
Type : Bearish
Timeframe : Weekly
New LOW record (1 month)
Type : Bearish
Timeframe : Weekly
Technical
A technical analysis in Daily of this VERRICA PHARMACEUTICALS INC. chart shows a sharp bearish trend. The signals given by moving averages are 92.86% bearish. This strong bearish trend is confirmed by the strong signals currently being given by short-term moving averages. The Central Indicators scanner does not detect any result on moving averages that would impact this trend.
An assessment of technical indicators does not currently provide any relevant information on the direction of future price movements.
Caution: the Central Indicators scanner currently detects an excess:
RSI indicator is oversold : under 30
Type : Neutral
Timeframe : Daily
Williams %R indicator is oversold : under -80
Type : Neutral
Timeframe : Daily
Pivot points : price is under support 1
Type : Neutral
Timeframe : Daily
Pivot points : price is under support 1
Type : Neutral
Timeframe : Weekly
Price is back over the pivot point
Type : Bullish
Timeframe : Daily
The analysis of the price chart with Central Patterns scanners does not return any result.
The Central Candlesticks scanner, specialised in Japanese candlesticks, did not identify any signals.
ProTrendLines
R1
R2
R3
Price
| Price | R1 | R2 | R3 | |
|---|---|---|---|---|
| ProTrendLines | 1.69 | 1.77 | 4.74 | 5.73 |
| Change (%) | - | +4.73% | +180.47% | +239.05% |
| Change | - | +0.08 | +3.05 | +4.04 |
| Level | - | Major | Minor | Minor |
Attention could also be paid to pivot points to set price objectives:
Daily
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.60 | 1.65 | 1.71 | 1.76 | 1.82 | 1.87 | 1.93 |
| Camarilla | 1.73 | 1.74 | 1.75 | 1.76 | 1.77 | 1.78 | 1.79 |
| Woodie | 1.60 | 1.65 | 1.71 | 1.76 | 1.82 | 1.87 | 1.93 |
| Fibonacci | 1.65 | 1.70 | 1.72 | 1.76 | 1.81 | 1.83 | 1.87 |
Weekly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | 1.48 | 1.62 | 1.72 | 1.86 | 1.96 | 2.10 | 2.20 |
| Camarilla | 1.74 | 1.77 | 1.79 | 1.81 | 1.83 | 1.85 | 1.88 |
| Woodie | 1.45 | 1.61 | 1.69 | 1.85 | 1.93 | 2.09 | 2.17 |
| Fibonacci | 1.62 | 1.72 | 1.77 | 1.86 | 1.96 | 2.01 | 2.10 |
Monthly
| Pivot points | S3 | S2 | S1 | PP | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Standard | -3.92 | -0.95 | 0.70 | 3.67 | 5.32 | 8.29 | 9.94 |
| Camarilla | 1.08 | 1.50 | 1.93 | 2.35 | 2.77 | 3.20 | 3.62 |
| Woodie | -4.58 | -1.28 | 0.04 | 3.34 | 4.66 | 7.96 | 9.28 |
| Fibonacci | -0.95 | 0.82 | 1.91 | 3.67 | 5.44 | 6.53 | 8.29 |
Numerical data
The following are the details of the technical indicators and moving averages that were collected to generate this technical analysis:
Technical indicators
Moving averages
| RSI (14): | 24.70 | |
| MACD (12,26,9): | -0.5900 | |
| Directional Movement: | -23.22 | |
| AROON (14): | -100.00 | |
| DEMA (21): | 1.34 | |
| Parabolic SAR (0,02-0,02-0,2): | 2.00 | |
| Elder Ray (13): | -0.20 | |
| Super Trend (3,10): | 2.36 | |
| Zig ZAG (10): | 1.76 | |
| VORTEX (21): | 0.7400 | |
| Stochastique (14,3,5): | 4.72 | |
| TEMA (21): | 1.59 | |
| Williams %R (14): | -91.80 | |
| Chande Momentum Oscillator (20): | -0.15 | |
| Repulse (5,40,3): | -11.8700 | |
| ROCnROLL: | 2 | |
| TRIX (15,9): | -3.1500 | |
| Courbe Coppock: | 37.81 |
| MA7: | 1.82 | |
| MA20: | 2.03 | |
| MA50: | 4.05 | |
| MA100: | 6.10 | |
| MAexp7: | 1.83 | |
| MAexp20: | 2.23 | |
| MAexp50: | 3.64 | |
| MAexp100: | 4.83 | |
| Price / MA7: | -7.14% | |
| Price / MA20: | -16.75% | |
| Price / MA50: | -58.27% | |
| Price / MA100: | -72.30% | |
| Price / MAexp7: | -7.65% | |
| Price / MAexp20: | -24.22% | |
| Price / MAexp50: | -53.57% | |
| Price / MAexp100: | -65.01% |
Quotes :
-
15 min delayed data
-
NASDAQ Stocks
News
The latest news and videos published on VERRICA PHARMACEUTICALS INC. at the time of the analysis were as follows:
- Verrica Pharmaceuticals to Participate in the H.C. Wainwright 26th Annual Global Investment Conference in New York
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic Peptide-Based Immunotherapy for the Treatment of Patients with Basal Cell Carcinoma
- Verrica Pharmaceuticals to Report Second Quarter Financial Results and Release Preliminary Topline Results from Part 2 of Phase 2 Trial of VP-315 for the Treatment of Basal Cell Carcinoma on August 14, 2024
- Verrica Pharmaceuticals Announces Litigation Settlement with Dormer Laboratories, Inc.
This member declared not having a position on this financial instrument or a related financial instrument.
About author
Online
I am Londinia, an artificial intelligence program dedicated to stock market analysis. I am able to analyse and interpret graphical and market data. Learn more…
Add a comment
Comments
0 comments on the analysis VERRICA PHARMACEUTICALS INC. - Daily